Rathbones secures Irish licence as it eyes Europe expansion October 7, 2026 Rathbones has secured a financial licence allowing it to begin operating in Ireland and the EU, as the wealth manager looks to extend its reach across Europe. The firm was granted a Markets in Financial Instruments Directive (MiFID) licence from the Central Bank of Ireland, which enables it to serve new and existing clients in [...]
CRH to Acquire Aggregate Operations in Denmark and Finland October 7, 2026 Transaction Advances CRH’s Strategy to Build Aggregates-led, Connected Portfolio Aligned With Growing Infrastructure Megatrends
Why British entrepreneurs hold the key to the cost-of-living crisis October 7, 2026 Ahead of the upcoming Budget, entrepreneur Tom Inskip explains why rewarding risk-taking is the only way to build a thriving, future-proof British economy. For better or worse, most people in my life would call me a ferocious optimist. Someone once joked, “when Skippy sees a shit on the road, he’s immediately looking around the corner [...]
UK AI health rules could give firms ‘competitive edge’ as ministers back overhaul October 6, 2026 Experts have said Britain’s new approach to regulating AI in healthcare could give UK tech firms a “competitive edge” by letting them prove their technology in the NHS earlier. The UK government on Tuesday accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, paving the way for a shake-up [...]
Waypoint Trading Solutions Launches Exchange and Market Data Management Solution in Partnership with SEAD Software October 6, 2026 AI-powered Wayfinder helps firms identify, manage and act on exchange and vendor changes
1stAveMachine Expands Experiential Offering, Names Jessica DeVirgilis as Lead October 6, 2026 New offering brings the production company’s filmmaking, design and technology expertise into live and immersive brand experiences
ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia October 6, 2026 CROWN is the first large, phase IIIb international trial to evaluate the investigational use of long-acting Cabenuva versus daily oral therapy in people with a history of antiretroviral treatment and unsuppressed HIV Results build on LATITUDE study and robust body of evidence supporting investigational use of long-acting cabotegravir + rilpivirine treatment in delivering viral suppression across treatment-experienced populations, including people with viremia at initiation Data to be shared with health authorities for regulatory review
Xsolla Shows Brand Owners How to Create Value for Video Players at Brand Licensing Europe With Rewarded Marketing October 6, 2026 Twenty-One Years of Game Commerce Comes to ExCeL London, October 6 to 8, With a New Way for Brands to Reward the Players They Have Been Trying to Reach for Years
Merrithew® Elevates the Wood Reformer Category with the Maple NX3 MAX™ October 6, 2026 Shaped by product engineers and expert trainers worldwide: more room for clients, faster transitions for instructors and a standout design for studios.
One Model Launches AI Impact, Extending Its Governed Data Platform to Measure AI Effectiveness October 6, 2026 A standalone solution built on the same governed, secure data platform enterprises already trust for workforce data, AI Impact uses prompt-level intelligence to reveal how AI is being used, how effectively, and where organizations can improve